Search

Abbott Laboratories

Fermé

SecteurSoins de santé

102.01 -1.26

Résumé

Variation du prix de l'action

24h

Actuel

Min

101.9

Max

102.71

Chiffres clés

By Trading Economics

Revenu

-149M

928M

Ventes

1.4B

13B

P/E

Moyenne du Secteur

35.058

56.597

BPA

1.31

Rendement du dividende

2.28

Marge bénéficiaire

7.369

Employés

122,000

EBITDA

-465M

1.8B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+21.96% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

2.28%

2.18%

Prochains Résultats

14 oct. 2026

Date du Prochain Détachement de Dividende

14 oct. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

24B

187B

Ouverture précédente

103.27

Clôture précédente

102.01

Sentiment de l'Actualité

By Acuity

30%

70%

63 / 339 Classement par Healthcare

Abbott Laboratories Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

12 sept. 2026, 00:01 UTC

Abbott Laboratories shares are higher in after-market trading, despite being below the 20-day moving average and a trend of lower closes.

11 sept. 2026, 23:01 UTC

Abbott Laboratories shares are higher in after-market trading, settling at a cumulative return of 1.60%. The U.S. budget deficit for August was $167 billion.

10 sept. 2026, 19:16 UTC

News

Abbott Laboratories received FDA approval for its TactiFlex Duo catheter. Shares are lower today, continuing a trend of declining prices over the past week.

9 sept. 2026, 23:26 UTC

News

Abbott Laboratories received U.S. FDA approval for its TactiFlex Duo ablation catheter. Shares are higher in after-market trading, reflecting a recovery from recent declines.

8 sept. 2026, 20:02 UTC

News

Abbott Laboratories shares are lower, reaching a four-week low of $106.72 amid weakness in the Health Care Equipment sector despite FDA approval for its ablation catheter.

4 sept. 2026, 20:07 UTC

Abbott Laboratories shares are lower, influenced by a strong jobs report that increased selling pressure across risk assets. The stock remains near its one-month trading range low.

3 sept. 2026, 23:31 UTC

Abbott Laboratories shares declined in after-market trading, reflecting ongoing weakness. The stock is near the lower end of its one-month range.

2 sept. 2026, 23:56 UTC

Abbott Laboratories shares are lower in after-market hours, reflecting a decline since Wednesday's close amid weaker-than-expected job growth reported by ADP.

1 sept. 2026, 23:51 UTC

Abbott Laboratories shares are higher in after-market hours amid notable trading activity. Rising oil prices and inflation concerns may influence Federal Reserve policy decisions.

31 août 2026, 23:32 UTC

Correlated Moves

Abbott Laboratories sees gains in after-market trading, reflecting strength in the health care equipment sector and broader positive trends among correlated assets.

28 août 2026, 23:16 UTC

Correlated Moves

Abbott Laboratories shares are higher in after-market hours, following a modest gain earlier, alongside Medtronic PLC's advance in the health care equipment sector.

27 août 2026, 22:51 UTC

Abbott Laboratories shares are trading higher in after-market hours, reversing three consecutive daily declines. No specific news was identified to explain the movement.

26 août 2026, 23:21 UTC

Abbott Laboratories is higher in after-market hours, reflecting broader market gains. The stock remains above its 20-day moving average despite recent fluctuations.

25 août 2026, 23:26 UTC

Abbott Laboratories shares declined after-market, with no specific news identified. Broader market sentiment was affected by falling crude oil prices amid eased geopolitical tensions.

24 août 2026, 23:01 UTC

Abbott Laboratories shares are trading lower in after-market hours. Broader market weakness and geopolitical tensions are contributing to the price movement.

21 août 2026, 23:01 UTC

Abbott Laboratories shares were lower in after-market trading, despite being above the 20-day moving average and near the upper end of their one-month range.

20 août 2026, 23:01 UTC

News

Abbott Laboratories settles litigation for $670 million over preterm infant formulas, trading lower in after-market hours following the news.

19 août 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours following a volatile session, despite trading above their 20-day moving average. No specific news was identified.

18 août 2026, 23:16 UTC

Shares of Abbott Laboratories are higher in after-market trading, remaining above the 20-day moving average and near the upper end of the one-month range.

17 août 2026, 23:41 UTC

Abbott Laboratories shares are trading lower in after-market hours. Broader market volatility is linked to rising crude oil prices and geopolitical tensions.

14 août 2026, 23:02 UTC

Abbott Laboratories shares are trading higher in after-market hours, showing strength above the 20-day moving average despite mixed market sentiment and declining U.S. retail sales.

13 août 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

12 août 2026, 23:46 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified for the decline. Broader market optimism follows recent inflation data.

11 août 2026, 19:16 UTC

News

Abbott Laboratories announced a partnership with Google Health to enhance glucose management through AI. Shares are trading higher amid positive market sentiment.

10 août 2026, 23:46 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

7 août 2026, 23:06 UTC

Abbott Laboratories shares declined slightly in after-market trading. The stock remains above its 20-day moving average and near the upper end of its one-month range.

6 août 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours, amid broader market weakness and rising initial jobless claims contributing to tightening expectations.

5 août 2026, 23:02 UTC

Abbott Laboratories shares are lower in after-market trading, following a brief peak post-close. Broader market conditions may be influencing sentiment amid weaker U.S. job growth data.

4 août 2026, 20:06 UTC

Abbott Laboratories shares are lower today, tracking broader market declines amid falling crude oil prices and ongoing discussions about potential peace talks.

3 août 2026, 23:06 UTC

Abbott Laboratories shares are near unchanged in after-market trading, positioned 7.52% above the 20-day moving average and near the upper end of the one-month range.

Comparaison

Variation de prix

Abbott Laboratories prévision

Objectif de Prix

By TipRanks

21.96% hausse

Prévisions sur 12 Mois

Moyen 124.333 USD  21.96%

Haut 135 USD

Bas 112 USD

Basé sur 15 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

15 ratings

15

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

63 / 339Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat